Copyright
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Oncol. Feb 24, 2021; 12(2): 54-60
Published online Feb 24, 2021. doi: 10.5306/wjco.v12.i2.54
Published online Feb 24, 2021. doi: 10.5306/wjco.v12.i2.54
Pancreatic cancer in the era of COVID-19 pandemic: Which one is the lesser of two evils?
Maitham A Moslim, Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, United States
Michael J Hall, Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111 , United States
Joshua E Meyer, Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, United States
Sanjay S Reddy, Department of Surgery, Fox Chase Cancer Center, Philadelphia, PA 19111, United States
Author contributions: Moslim MA contributed to the study concept and design, drafted the manuscript; Moslim MA, Hall MJ, Meyer JE and Reddy SS contributed to the critical revision of the manuscript for important intellectual content; Moslim MA and Reddy SS did final approval of the submitted version.
Conflict-of-interest statement: There are no conflicts of interest to be disclosed.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Sanjay S Reddy, FACS, MD, Attending Doctor, Department of Surgery, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, United States. sanjay.reddy@fccc.edu
Received: December 25, 2020
Peer-review started: December 25, 2020
First decision: January 11, 2021
Revised: January 12, 2021
Accepted: February 4, 2021
Article in press: February 4, 2021
Published online: February 24, 2021
Peer-review started: December 25, 2020
First decision: January 11, 2021
Revised: January 12, 2021
Accepted: February 4, 2021
Article in press: February 4, 2021
Published online: February 24, 2021
Core Tip
Core Tip: Pancreatic adenocarcinoma remains one of the deadliest malignancies affecting the older population; Oncological treatment protocols must adapt to the coronavirus disease 2019 era; Neoadjuvant treatment and further conducting a safe surgery while protecting patients in a controlled environment can improve oncological outcomes.